Patents by Inventor Wentao WEI
Wentao WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12099049Abstract: Provided are a method and device for recognizing hook effect in immune turbidimetry, and a computer readable medium. This method generates a reaction curve using light signals measured in a predetermined time period by immune reaction of analyte in a sample, and uses distribution information of the reaction curve in the predetermined time period to determine whether the sample has hook effect. This method only uses measurement information of a small predetermined time period in entire reaction time to determine whether a sample has hook effect, and terminates the test in time, thus accelerating the speed of immune turbidimetry detection of samples with hook effect.Type: GrantFiled: March 3, 2022Date of Patent: September 24, 2024Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Inventors: Wenbo Zheng, Bo Ye, Wentao Wei
-
Publication number: 20240168554Abstract: An objective of the present disclosure is to provide a domain adaptation method and system for gesture recognition, which relates to the field of gesture recognition technologies. The domain adaptation method for gesture recognition includes: obtaining a to-be-recognized target domain surface electromyography signal of a user; separately inputting the to-be-recognized target domain surface electromyography signal into multiple target domain gesture recognition models, to obtain target domain gesture recognition results under multiple source-specific views, where source domains of training data used by different target domain gesture recognition models are different; and determining a gesture category of the to-be-recognized target domain surface electromyography signal according to the gesture recognition results under multiple source-specific views and a weight under each source-specific view.Type: ApplicationFiled: November 21, 2023Publication date: May 23, 2024Applicant: Nanjing University of Science and TechnologyInventors: Wentao WEI, Linyan REN, Bowen ZHOU
-
Patent number: 11382222Abstract: An LED display panel includes main frame made of a lightweight material, a supporting component and a control box. The main frame includes a first end surface for mounting a display screen and a second end surface opposing the first end surface. The supporting component includes a supporting tube and a plurality of supporting members. Fixing parts are arranged on peripheral edges of the second end surface, and the plurality of supporting members are correspondingly mounted on the fixing parts. A tube fixing part is arranged on an end of the supporting member far away from the second end surface, and the supporting tube is fixed on the tube fixing part. A power supply, a control system and a signal transmission system are arranged in the control box, and the control system and the signal transmission system are electrically connected to the power supply.Type: GrantFiled: November 13, 2019Date of Patent: July 5, 2022Assignee: SHENZHEN INFILED ELECTRONICS CO., LTDInventors: Zongchao Hao, Qiuhe Liu, Wentao Wei
-
Publication number: 20220187278Abstract: Provided are a method and device for recognizing hook effect in immune turbidimetry, and a computer readable medium. This method generates a reaction curve using light signals measured in a predetermined time period by immune reaction of analyte in a sample, and uses distribution information of the reaction curve in the predetermined time period to determine whether the sample has hook effect. This method only uses measurement information of a small predetermined time period in entire reaction time to determine whether a sample has hook effect, and terminates the test in time, thus accelerating the speed of immune turbidimetry detection of samples with hook effect.Type: ApplicationFiled: March 3, 2022Publication date: June 16, 2022Inventors: Wenbo ZHENG, Bo YE, Wentao WEI
-
Publication number: 20210378111Abstract: An LED display panel includes main frame made of a lightweight material, a supporting component and a control box. The main frame includes a first end surface for mounting a display screen and a second end surface opposing the first end surface. The supporting component includes a supporting tube and a plurality of supporting members. Fixing parts are arranged on peripheral edges of the second end surface, and the plurality of supporting members are correspondingly mounted on the fixing parts. A tube fixing part is arranged on an end of the supporting member far away from the second end surface, and the supporting tube is fixed on the tube fixing part. A power supply, a control system and a signal transmission system are arranged in the control box, and the control system and the signal transmission system are electrically connected to the power supply.Type: ApplicationFiled: November 13, 2019Publication date: December 2, 2021Applicant: SHENZHEN INFILED ELECTRONICS CO., LTDInventors: Zongchao HAO, Qiuhe LIU, Wentao WEI
-
Patent number: 10221231Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.Type: GrantFiled: April 24, 2017Date of Patent: March 5, 2019Assignee: VIVA BIOTECH (SHANGHAI) LTD.Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
-
Patent number: 10106595Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.Type: GrantFiled: April 24, 2017Date of Patent: October 23, 2018Assignee: VIVA BIOTECH (SHANGHAI) LTD.Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
-
Publication number: 20170226187Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.Type: ApplicationFiled: April 24, 2017Publication date: August 10, 2017Applicant: VIVA BIOTECH (SHANGHAI) LTD.Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
-
Publication number: 20170226186Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.Type: ApplicationFiled: April 24, 2017Publication date: August 10, 2017Applicant: VIVA BIOTECH (SHANGHAI) LTD.Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
-
Patent number: 9670252Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.Type: GrantFiled: February 27, 2015Date of Patent: June 6, 2017Assignee: VIVA BIOTECH (SHANGHAI) LTD.Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
-
Publication number: 20150166609Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.Type: ApplicationFiled: February 27, 2015Publication date: June 18, 2015Inventors: Jianhua CAI, Jian SHEN, Fan JIANG, Na LI, Wentao WEI, Xiuhong ZENG, Xiaoyan SU, Min HAN, Delin REN, Chen MAO